7
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Antidiuretic Hormone and Atrial Natriuretic Peptide During Lower Body Negative or Positive Pressure in Hypertensive Patients with and Without Left Ventricular Hypertrophy

, , , , , , , & show all
Pages 717-732 | Received 11 Mar 1991, Accepted 21 Jan 1992, Published online: 03 Jul 2009
 

Abstract

Aim of the study was to evaluate the effect of cardiopulmonary receptors activation and deactivation on antidiuretic hormone (ADH) and atrial natriuretic peptide (ANP) incretion in hypertensive and normotensive subjects.

Twenty-one male subjects, 7 normotensives and 14 mild hypertensives, 7 without and 7 with left ventricular hypertrophy (LVH) were admitted to the study. Each subject underwent selective loading and unloading of cardiopulmonary receptors, by application of a positive (LBPP) or negative (LBNP) pressure to the lower body. Blood samples were taken for measurement of ANP, ADH, PRA, immunoreactive renin, aldosterone, noradrenaline and adrenaline.

ADH plasma concentration increased during cardiopulmonary receptors inhibition, but this increase became statistically significant (p<0.05) at a step of LBNP (-40 mm Hg), in which an involvement of the sinoaortic receptors cannot be excluded.

ANP plasma levels increased progressively during LBPP (p<0.05 at least).

These changes were significantly reduced in hypertensive patients with LVH.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.